<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 3</label>
 <caption>
  <p>Enrolment number and publishing timeline for completed studies</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Registration number</th>
    <th>Type of study</th>
    <th>Treatment</th>
    <th>Planned enrolment (
     <bold>
      <italic>n</italic>
     </bold>)
    </th>
    <th>Total patients
     <sup>
      <bold>1</bold>
     </sup> (
     <bold>
      <italic>n</italic>
     </bold>)
    </th>
    <th>H1N1 patients
     <sup>
      <bold>1</bold>
     </sup> (
     <bold>
      <italic>n</italic>
     </bold>)
    </th>
    <th>First patient enrolment
     <sup>
      <bold>1</bold>
     </sup> (month, year)
    </th>
    <th>Last patient enrolment
     <sup>
      <bold>1</bold>
     </sup> (month, year)
    </th>
    <th>Date published (month, year)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="9">
     <bold>Enrolment commenced before pandemic</bold>
    </td>
   </tr>
   <tr>
    <td> NCT00298233</td>
    <td>Phase 2</td>
    <td>Oseltamivir</td>
    <td>400</td>
    <td>326</td>
    <td>72</td>
    <td>Apr. 2007</td>
    <td>Feb. 2010</td>
    <td>May 2013 [
     <xref ref-type="bibr" rid="CR8">8</xref>]
    </td>
   </tr>
   <tr>
    <td> NCT00391768</td>
    <td>Phase 1/2</td>
    <td>Oseltamivir</td>
    <td>108</td>
    <td>87</td>
    <td>37</td>
    <td>Jan. 2007</td>
    <td>Apr. 2010</td>
    <td>Mar. 2013 [
     <xref ref-type="bibr" rid="CR9">9</xref>]
    </td>
   </tr>
   <tr>
    <td colspan="9">
     <bold>Enrolment commenced during pandemic</bold>
    </td>
   </tr>
   <tr>
    <td> NCT00949533</td>
    <td>Phase 3</td>
    <td>Oseltamivir</td>
    <td>125</td>
    <td>37</td>
    <td>Unknown</td>
    <td>Aug. 2009</td>
    <td>Oct. 2010</td>
    <td>Apr. 2016 (Unp)</td>
   </tr>
   <tr>
    <td> NCT00957996</td>
    <td>Phase 3</td>
    <td>Peramivir</td>
    <td>300</td>
    <td>127</td>
    <td>94</td>
    <td>Oct. 2009</td>
    <td>Oct. 2010</td>
    <td>Aug. 2013 [
     <xref ref-type="bibr" rid="CR10">10</xref>]
    </td>
   </tr>
   <tr>
    <td> NCT01199744</td>
    <td>Prospective cohort</td>
    <td>Zanamivir</td>
    <td>N/R</td>
    <td>1575</td>
    <td>Unknown</td>
    <td>Nov. 2009</td>
    <td>Apr. 2010</td>
    <td>Mar. 2011(Unp)</td>
   </tr>
   <tr>
    <td> NCT01014988</td>
    <td>Phase 2</td>
    <td>Zanamivir</td>
    <td>150</td>
    <td>130</td>
    <td>92</td>
    <td>Nov. 2009</td>
    <td>Sep. 2011</td>
    <td>Feb. 2014 [
     <xref ref-type="bibr" rid="CR11">11</xref>]
    </td>
   </tr>
   <tr>
    <td> NCT01052961</td>
    <td>Phase 4</td>
    <td>Oseltamivir</td>
    <td>400</td>
    <td>155</td>
    <td>34</td>
    <td>Jan. 2010</td>
    <td>Jun. 2012</td>
    <td>Dec. 2013 [
     <xref ref-type="bibr" rid="CR12">12</xref>]
    </td>
   </tr>
   <tr>
    <td> NCT01050257</td>
    <td>Phase 3</td>
    <td>Oseltamivir</td>
    <td>200</td>
    <td>118</td>
    <td>Unknown</td>
    <td>Jan. 2010</td>
    <td>Sep. 2012</td>
    <td>Aug. 2013 (Unp)</td>
   </tr>
   <tr>
    <td> NCT01068912</td>
    <td>Phase 2</td>
    <td>Favipiravir</td>
    <td>384</td>
    <td>530</td>
    <td>110</td>
    <td>Feb. 2010</td>
    <td>May 2012</td>
    <td>Feb. 2014 (Unp)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Enrolment number and publishing timeline for completed studies where results are published in the literature (date followed by reference) or on the clinical trials registration site (date followed by Unp)</p>
  <p>
   <italic>N/R</italic> not reported
  </p>
  <p>
   <sup>1</sup>Where conflict existed between numbers in the clinical trial record and publication, publication numbers were used
  </p>
 </table-wrap-foot>
</table-wrap>
